We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+5.52%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$5.65B
AUM Growth
+$471M
(+9.1%)
Cap. Flow
+$283M
Cap. Flow
% of AUM
5.01%
Top 10 Holdings %
Top 10 Hldgs %
17.56%
Holding
1,507
New
476
Increased
192
Reduced
202
Closed
448
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$14.4M |
| 2 |
argenx
ARGX
|
+$13.4M |
| 3 |
Compañía de Minas Buenaventura
BVN
|
+$13.1M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$11.3M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KraneShares CSI China Internet ETF
KWEB
|
+$16.7M |
| 2 |
Sabre
SABR
|
+$12.5M |
| 3 |
UBS Group
UBS
|
+$10.2M |
| 4 |
Walt Disney
DIS
|
+$9.97M |
| 5 |
CBL
CBL Properties
CBL
|
+$7.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.56% |
| 2 | Technology | 1.89% |
| 3 | Consumer Discretionary | 0.9% |
| 4 | Communication Services | 0.87% |
| 5 | Industrials | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Repligen
RGEN
$8.3B
| $2.97M | 0.05% |
+21,000
| New | +$3.37M |
|
402
PUT
Teva Pharmaceuticals
TEVA
$40.2B
| $2.97M | 0.05% |
+394,100
| New | +$3.2M |
|
403
PUT
Helen of Troy
HELE
$676M
| $2.96M | 0.05% |
27,400
| – | – |
|
404
MetLife
MET
$62B
| $2.95M | 0.05% |
+52,248
| New | +$2.9M |
|
405
PUT
AngloGold Ashanti
AU
$41.3B
| $2.95M | 0.05% |
+140,000
| New | +$3.53M |
|
|
KYNB
406
CALL
Kyntra Bio
KYNB
$27.4M
| $2.94M | 0.05% |
43,628
+36,708
| +530% | +$15.2M |
|
407
CALL
Telefônica Brasil
VIV
$20.3B
| $2.94M | 0.05% |
322,000
-2,200
| -0.7% | -$18.4K |
|
408
CALL
Freeport-McMoran
FCX
$91.5B
| $2.93M | 0.05% |
73,200
| – | – |
|
409
CALL
Vornado Realty Trust
VNO
$7.51B
| $2.92M | 0.05% |
+161,000
| New | +$2.37M |
|
|
410
CALL
Helen of Troy
HELE
$676M
| $2.92M | 0.05% |
27,000
| – | – |
|
411
PUT
Ascendis Pharma A/S
ASND
$16B
| $2.9M | 0.05% |
32,500
+7,500
| +30% | +$653K |
|
412
CALL
American International
AIG
$41.8B
| $2.9M | 0.05% |
50,400
-33,800
| -40% | -$1.81M |
|
413
CALL
iHeartMedia
IHRT
$602M
| $2.9M | 0.05% |
795,800
-3,500
| -0.4% | -$11.6K |
|
|
LSXMK
414
PUT
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $2.86M | 0.05% |
112,963
| – | – |
|
415
CALL
Groupon
GRPN
$1.05B
| $2.84M | 0.05% |
+480,000
| New | +$2.12M |
|
416
PUT
SiriusXM
SIRI
$10.2B
| $2.83M | 0.05% |
62,500
-99,940
| -62% | -$3.77M |
|
417
PUT
Neurocrine Biosciences
NBIX
$16.7B
| $2.83M | 0.05% |
30,000
| – | – |
|
|
SAGE
418
PUT
DELISTED
Sage Therapeutics
SAGE
| $2.82M | 0.05% |
60,000
+30,000
| +100% | +$1.49M |
|
419
FTAI Aviation
FTAI
$23.1B
| $2.8M | 0.05% |
88,580
+52,866
| +148% | +$1.5M |
|
420
PUT
NRG Energy
NRG
$29.2B
| $2.8M | 0.05% |
+75,000
| New | +$2.55M |
|
421
CALL
DoubleVerify
DV
$1.8B
| $2.72M | 0.05% |
70,000
-10,000
| -13% | -$323K |
|
422
XP
XP
$8.8B
| $2.72M | 0.05% |
+116,000
| New | +$1.97M |
|
423
Vistra
VST
$52.6B
| $2.71M | 0.05% |
103,300
-34,863
| -25% | -$852K |
|
424
PUT
Huntsman Corp
HUN
$1.76B
| $2.7M | 0.05% |
+100,000
| New | +$2.6M |
|
425
CALL
Trex
TREX
$4.66B
| $2.7M | 0.05% |
+41,200
| New | +$2.3M |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2023 Portfolio in Review
As of Q2 2023, Caption Management held 1,507 positions worth $5.65B, up 9.1% from $5.18B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Caption Management deployed $283M of net new capital in Q2 2023, opening 476 new positions and adding to 192 existing holdings. Its largest new stake was Lockheed Martin: 31,000 shares worth $14.3M.
By sector, the portfolio is most concentrated in Healthcare at 2.6% of assets, up from 2% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Sabre, an estimated $12.5M trimmed.
- Caption Management's largest Q2 2023 buy was Lockheed Martin: 31,000 shares worth $14.3M.
- Caption Management added most to State Street SPDR S&P Biotech ETF in Q2 2023, an estimated $11M increase.
- Caption Management's biggest Q2 2023 reduction was Sabre, cutting an estimated $12.5M.
- Caption Management fully exited KraneShares CSI China Internet ETF in Q2 2023, selling an estimated $16.7M.
- Caption Management's ten largest holdings make up 18% of its $5.65B portfolio in Q2 2023.
- Caption Management opened 476 new positions and closed 448 in Q2 2023.
- Caption Management's portfolio value rose 9.1% quarter-over-quarter to $5.65B.
Based on Caption Management's 13F filing for Q2 2023, filed 14 Aug 2023.